---
title: "Viatris Inc. Stock Falls Monday, Underperforms Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293255239.md"
description: "Viatris Inc. (VTRS) shares fell 1.74% to $16.99 on Monday, underperforming the broader market as the S&P 500 and Dow Jones also declined. This marks the second consecutive day of losses for Viatris. The stock remains 3.85% below its 52-week high of $17.67 reached in July. Trading volume was lower than the 50-day average."
datetime: "2026-07-20T21:07:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293255239.md)
  - [en](https://longbridge.com/en/news/293255239.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293255239.md)
---

# Viatris Inc. Stock Falls Monday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Viatris Inc. (VTRS) slipped 1.74% to $16.99 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.19% to 7,443.28 and Dow Jones Industrial Average falling 0.59% to 51,839.26.

This was the stock's second consecutive day of losses.

Viatris Inc. closed 3.85% short of its 52-week high of $17.67, which the company reached on July 17th.

Trading volume (7.9 M) remained 3.2 million below its 50-day average volume of 11.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 20, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-20-26 1707ET

### Related Stocks

- [VTRS.US](https://longbridge.com/en/quote/VTRS.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [What Viatris (VTRS)'s FDA Approval of Weekly Gwyn Lo Contraceptive Patch Means For Shareholders](https://longbridge.com/en/news/294317648.md)
- [Viatris runs into FDA roadblock over on-the-go inhaler claim](https://longbridge.com/en/news/294353190.md)
- [Viatris’ Quarterly Earnings Preview: What You Need to Know](https://longbridge.com/en/news/293460193.md)
- [These large-cap stocks combine A-rated profitability with low forward P/E ratios](https://longbridge.com/en/news/293947853.md)
- [Viatris Inc. Stock Falls Friday, Underperforms Market](https://longbridge.com/en/news/294556177.md)